Nanobiosystems for Antimicrobial Drug-Resistant Infections.
Ontology highlight
ABSTRACT: The worldwide increased bacterial resistance toward antimicrobial therapeutics has led investigators to search for new therapeutic options. Some of the options currently exploited to treat drug-resistant infections include drug-associated nanosystems. Additionally, the use of bacteriophages alone or in combination with drugs has been recently revisited; some studies utilizing nanosystems for bacteriophage delivery have been already reported. In this review article, we focus on nine pathogens that are the leading antimicrobial drug-resistant organisms, causing difficult-to-treat infections. For each organism, the bacteriophages and nanosystems developed or used in the last 20 years as potential treatments of pathogen-related infections are discussed. Summarizing conclusions and future persp
SUBMITTER: Gkartziou F
PROVIDER: S-EPMC8143556 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA